Dr Davin Lim | Dermatologist The Melasma Clinic, Brisbane | Sydney We have been using it for the past 9 years, initially as IV formulations (drip) during the skin lightening craze around 2015 (primarily led by Asian countries)
Moreover, because GLP-1R is expressed throughout the body, stimulation with a GLP-1R agonist or indirectly with a DPP-IV inhibitor can have a broad systemic effect on systemic metabolism, which, in turn, ameliorates peripheral and central insulin resistance in AD and MD (Athauda and Foltynie, 2016)
Protocol: AOD 9604: 500mcg morning fasted BPC-157: 250-500mcg twice daily (morning and evening) BPC-157 accelerates healing and reduces inflammation, letting you train harder during your cut
This product is supplied as a lyophilized powder for controlled laboratory research use
Gradual dose reduction may help stabilize appetite signals during the transition